Following the publication of the results of the Phase III MAGIC trial in Future Oncologyavailable here – we’ve summarized some of the key trial data in the infographic below. Scroll down to learn more about the efficacy of APF530 for the treatment of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.